Synergistic combination of IAP antagonism and immunotherapy to treat brain cancers Brain cancers can be exceptionally challenging to treat, and new therapies are needed. TYPE DE SUBVENTION Subventions d'équipe Domaine de recherche Le cancer Province Ontario DATE DE DÉBUT 2016